How Eli Lilly's leader won Trump's favor [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
David Ricks, CEO of the Indianapolis-based pharmaceutical manufacturer Eli Lilly, is putting on a masterclass. Trump demonstrated his affection on Friday when he — not for the first time — praised the company executive. “The head of Eli Lilly, and I really mean it, an unbelievable executive, an unbelievable guy, one of the most successful companies,” Trump said during remarks about his “ Great Healthcare Plan.” For his part, over Trump's second term, Ricks, who took Eli Lilly's helm in 2017, has used everything from flattery to concrete concessions to win over the president — even as Trump'sadministration targets the pharmaceutical industry. At the same time, Ricks has kept a steady eye on his company's own interests and bottom line. Eli Lilly's heartland roots, $500,000 contribution to Trump's inauguration fund , promises to build more facilities in America and prominent role in Trump's most-favored-nation deal for weight loss drugs have helped Ricks become one of Trump's fav
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Novo Nordisk (NYSE:NVO) Valuation Check After Sharp 1 Month Rebound And Mixed Long Term Returns [Yahoo! Finance]Yahoo! Finance
- Airlines have 580 million reasons to like GLP-1 weight-loss drugs, analysis finds [Yahoo! Finance]Yahoo! Finance
- Compounder sues Lilly and Novo for suppressing GLP-1RA competition [Yahoo! Finance]Yahoo! Finance
- Drugmakers hike medicine prices in 2026. How much more will you spend? [USA TODAY]USA TODAY
- Eli Lilly vs. Novo Nordisk: Which Is the Better Stock Buy? [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 11/6/25 - Beat
NVO
Sec Filings
- 12/23/25 - Form 6-K
- 11/25/25 - Form 6-K
- 11/24/25 - Form 6-K
- NVO's page on the SEC website